Stevanato Group S.p.A. (STVN) PT Lowered to $32 at KeyBanc Mar 5, 2026 09:12AM
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks' Dec 8, 2025 07:11AM
KeyBanc: White House GLP-1 Deals Boost Growth Potential for Key Suppliers Nov 20, 2025 07:30AM
KeyBanc Takeaways from This Year's BioProcess International Conference Sep 23, 2025 07:29AM
KeyBanc on the Potential Breakout Year for GLP-1 Beneficiaries West Pharmaceutical (WST) and STVN Jun 18, 2025 09:50AM


Mar 11, 2025 04:30PM Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Jan 27, 2025 06:05AM KeyBanc Highlights WST, GXIG, and STVN as GLP-1 Estimates Raise
Dec 23, 2024 05:30AM KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results
Mar 26, 2024 04:10PM Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
Mar 21, 2024 11:46PM Stevanato Group S.p.A. (STVN) Announces Pricing of Upsized Public Offering of Ordinary Shares
Mar 21, 2024 11:45PM Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
Mar 11, 2024 05:05PM Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Mar 14, 2023 06:00AM Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 17, 2022 04:30PM Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 9, 2022 06:20AM Stevanato Group S.p.A. (STVN) Benefits from the Uptick in Biologics - KeyBanc
Dec 10, 2021 07:33AM Companies with NDRs 12/10
Aug 17, 2021 08:49AM Stevanato Group Announces Underwriters’ Partial Exercise of Over-Allotment Option
Jul 16, 2021 12:00PM Stevanato Group S.p.A. (STVN) IPO Opens 21% Lower
Jul 16, 2021 05:01AM Stevanato Group (STVN) Prices 32M Share IPO at $21/sh
Jul 15, 2021 06:41PM Stevanato Group Announces Pricing of Initial Public Offering